Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-10-048893
Filing Date
2010-03-05
Accepted
2010-03-05 15:46:47
Documents
2
Group Members
ASTELLAS US HOLDING, INC.RUBY ACQUISITION, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE TO dsctota.htm SC TO-T/A 38810
2 LETTER REGARDING THE TENDER OFFER dex99a5c.htm EX-99.(A)(5)(C) 13329
  Complete submission text file 0001193125-10-048893.txt   54171
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-37954 | Film No.: 10660631
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

EIN.: 132971791
Type: SC TO-T/A